Free Trial

Canopy Growth (WEED) Competitors

Canopy Growth logo
C$2.46 -0.23 (-8.55%)
As of 02:20 PM Eastern

WEED vs. CMED, EMC, OGI, ICC, LEAF, MGW, BE, BLO, SL, and MJN

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include CanniMed Therapeutics (CMED), Emblem (EMC), Organigram (OGI), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry.

Canopy Growth vs.

Canopy Growth (TSE:WEED) and CanniMed Therapeutics (TSE:CMED) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, community ranking, earnings, risk and institutional ownership.

CanniMed Therapeutics has a net margin of 0.00% compared to Canopy Growth's net margin of -201.27%. CanniMed Therapeutics' return on equity of 0.00% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-201.27% -108.18% -3.83%
CanniMed Therapeutics N/A N/A N/A

9.4% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Canopy Growth had 8 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 8 mentions for Canopy Growth and 0 mentions for CanniMed Therapeutics. Canopy Growth's average media sentiment score of 1.31 beat CanniMed Therapeutics' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company Overall Sentiment
Canopy Growth Positive
CanniMed Therapeutics Neutral

CanniMed Therapeutics has lower revenue, but higher earnings than Canopy Growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy GrowthC$519.68M0.76-C$1.05B-C$6.85-0.36
CanniMed TherapeuticsN/AN/AN/AN/AN/A

Canopy Growth currently has a consensus target price of C$5.64, suggesting a potential upside of 129.20%. Given Canopy Growth's stronger consensus rating and higher probable upside, equities research analysts plainly believe Canopy Growth is more favorable than CanniMed Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
4 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.20
CanniMed Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Canopy Growth received 483 more outperform votes than CanniMed Therapeutics when rated by MarketBeat users. However, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 61.96% of users gave Canopy Growth an outperform vote.

CompanyUnderperformOutperform
Canopy GrowthOutperform Votes
640
61.96%
Underperform Votes
393
38.04%
CanniMed TherapeuticsOutperform Votes
157
75.85%
Underperform Votes
50
24.15%

Summary

Canopy Growth beats CanniMed Therapeutics on 8 of the 12 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WEED vs. The Competition

MetricCanopy GrowthDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$395.73MC$2.17BC$5.33BC$5.95B
Dividend Yield4.80%2.92%5.20%6.32%
P/E Ratio-0.363.9726.7429.43
Price / Sales0.76569.72394.49943.42
Price / Cash1.6310.2538.3283.71
Price / Book0.426.956.743.99
Net Income-C$1.05BC$20.70BC$3.23BC$301.32M
7 Day Performance7.42%-0.44%0.13%0.82%
1 Month Performance43.02%3.33%8.83%6.81%
1 Year Performance-80.37%96.02%18.45%17.18%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WEED
Canopy Growth
1.4836 of 5 stars
C$2.46
-8.6%
C$5.64
+129.2%
-79.1%C$395.73MC$519.68M-0.362,700Positive News
CMED
CanniMed Therapeutics
N/AN/AN/AN/AC$668.44MN/A0.00147,000
EMC
Emblem
N/A$1.88
+1.6%
N/A+0.0%$245.45M$5.71M-9.89N/A
OGI
Organigram
3.1359 of 5 stars
C$1.87
+8.1%
C$3.33
+77.8%
-26.2%C$231.02MC$180.58M-3.95987Positive News
High Trading Volume
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533,684.0095.29N/AGap Up
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150
MGW
Maple Leaf Green World
N/AC$0.79
+777.8%
N/A+0.0%C$111.69MN/A0.00N/AGap Up
BE
Beleave
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
BLO
Cannabix Technologies
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
SL
Supreme Cannabis Company Inc,
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
High Trading Volume
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/A0.007,600

Related Companies and Tools


This page (TSE:WEED) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners